A new oral weight loss medication, orforglipron, demonstrated meaningful weight loss results in phase 3 trials, potentially ...

Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's ...

The latest results from a trial of a pill form of popular GLP-1 medications offer enough information for Eli Lilly to request global regulatory approval this year, the company said Tuesday. Lilly, ...

An experimental obesity pill that works in a different way from the wildly popular Ozempic may help people lose weight, according to results from a small, preliminary human trial. Ozempic and other ...

These days there is no escaping the popularity of taking a weight loss drug to shed the pounds. Over the past four years, GLP-1 drugs such as Ozempic (prescribed for Type 2 diabetes), Wegovy and ...

A GLP-1 drug in pill form — no needles required — helped people with obesity and Type 2 diabetes lose 10% of their body weight and lower their blood sugar levels, pharmaceutical giant Eli Lilly ...

ORLANDO, Fla. -- A second study confirms that an experimental diet pill can help people lose weight and keep it off for up to two years, setting the stage for its maker to seek approval to sell it in ...

A pill version of semaglutide — the active ingredient in Ozempic and Wegovy — helped people lose more than 13% of their body weight in a late-stage trial, pharmaceutical giant Novo Nordisk announced ...